Urol. praxi, 2011; 12(4): 229-233

Pharmacotherapy and its pitfalls in the treatment of urgent incontinence and overactive bladder

MUDr.Miroslava Romžová, MUDr.Marie Hurtová, MUDr.Jaroslav Pacovský, Ph.D., MUDr.Miloš Broďák, Ph.D.
Urologická klinika Fakultní nemocnice Hradec Králové

Pharmacotherapy is the first line therapy in the treatment of the overactive bladder and the urgent incontinence. It effects thru the active

substance or the metabolite on the cell or neuronal receptor. This receptor’s bind induces target organ. Many organs have same types

of the receptors. That is the reason, why one medicament operates on different organs. That leads to eligible and ineligible effect.

Keywords: urgent incontinence, overactive bladder, pharmacotherapy, unwished side-effect

Published: August 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Romžová M, Hurtová M, Pacovský J, Broďák M. Pharmacotherapy and its pitfalls in the treatment of urgent incontinence and overactive bladder. Urol. praxi. 2011;12(4):229-233.
Download citation

References

  1. http://www.urotoday.com/urinary-incontinence-ui-983/classification-2944.html.
  2. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community dwelling populations. J Am Geriatr Soc, 1990; 38: 273. Go to original source... Go to PubMed...
  3. Verner P. Porovnání účinnosti a vedlejších účinků anticholinergik při léčbě OAB. Urolog. Praxi, 2010; 11(5): 241-246.
  4. Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuskarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol, 2005; 48: 5-26. Go to original source... Go to PubMed...
  5. Romžová M, Hurtová M, Pacovský J, Broďák M. Inkontinence moče ve stáří. Urolog. Praxi, 2010; 11(3): 119-123.
  6. Poršová M, Kolombo I, Porš J, Kobzanová R, Pabišta R. Urgentní mikce a inkontinence a možnosti jejich farmakologické léčby. Urol. Praxi, 2008; 9(6): 302-306.
  7. Andersson KE. Antimuscarinic mechanism and the overactive detrusor: an update. Eur. Urol., 2011; 59: 377-386. Go to original source... Go to PubMed...
  8. Topinková E. Úskalí farmakoterapie urgentní inkontinence a hyperaktivního močového měchýře. Lékařské listy, 2009; 18: 21-25.
  9. Drlík P. Nykturie - současné možnosti terapie. Urol. Praxi, 2010; 11(4): 176-179.
  10. Saks EK, Lily AA. Pharmacologic management of overactive bladder. The female patient, 2010; 11(35): 24-29.
  11. Krhut J. Současný pohled na diagnostiku inkontinence moči a léčbu. Postgraduální med. 2008; 3: 32-39.
  12. Kuo HC, Liao CH, Chung SD. Adverse events of intravesical Botulinum Toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur. Urol., 2010; 58: 919-926. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.